Mizuho Securities Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $155
RBC Capital Upgrades Teleflex(TFX.US) to Buy Rating, Cuts Target Price to $150
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $140
Truist Cuts Price Target on Teleflex to $140 From $149, Keeps Hold Rating
Teleflex Analyst Ratings
JMP Securities Maintains Teleflex(TFX.US) With Hold Rating
JMP Securities Maintains Teleflex(TFX.US) With Hold Rating
Teleflex's Strategic Uncertainty and Growth Challenges Justify Hold Rating
RBC Capital Downgrades Teleflex(TFX.US) to Hold Rating, Cuts Target Price to $155
RBC Capital Sticks to Their Hold Rating for Teleflex (TFX)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teleflex (TFX) and Voyager Therapeutics (VYGR)
Needham Maintains Teleflex(TFX.US) With Hold Rating
Teleflex Analyst Ratings
Teleflex's Uncertain Future: Hold Rating Amidst Market Decline and Spin-Off Skepticism
Teleflex Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Adjusts Price Target on Teleflex to $191 From $275, Keeps Overweight Rating
Morgan Stanley Maintains Teleflex(TFX.US) With Buy Rating, Cuts Target Price to $191
Teleflex Cut to Underperform From Neutral by B of A Securities
B of A Securities Downgrades Teleflex to Underperform, Lowers Price Target to $140
Teleflex Analyst Ratings